
Every picture tells a story
Cardiologists are looking beyond on-screen images of the heart to extract data behind these scans that describe coronary dysfunctions and can reveal hard evidence of the cause of disease reports John Brosky.
Cardiologists are looking beyond on-screen images of the heart to extract data behind these scans that describe coronary dysfunctions and can reveal hard evidence of the cause of disease reports John Brosky.
Manufactured by Amsterdam-based company CardiaTech Holland BV, which specialises in defibrillators and AED trainer units, the CardiAid Automated External Defibrillator (AED) has been designed to provide electroshock treatment for sudden cardiac arrest (SCA).
Patients with atrial fibrillation, so at risk of stroke, are usually treated with medication to prevent coagulation. The Hanover Medical School (MHH) has devised an alternative treatment.
Western societies are struggling to pay for their ever increasing medical budgets. In the US up to 393 billion US-$ were spent in 2005 for cardiovascular diseases alone. Based on epidemiologic studies in primary prevention it is reasonable to estimate that 30% of coronary heart disease and stroke could be prevented by 2.5 hours of brisk walking per week.
Surviving a heart attack depends upon where you live in Europe. For cardiologists that is unacceptable. A majority of European countries can deliver life-saving primary percutaneous coronary interventions (P-PCI), yet too often these centres are closed over weekends or after working hours - when 50% of all myocardial infarctions occur.
Measuring left ventricle ejection fraction (LVEF) is the gold standard for determining the risk of cardiac death or sudden cardiac death after a myocardial infarction (MI). If LVEF is below 30%, a cardioverter-defibrillator is implanted to avoid such an event.
A potentially life-saving kiosk has been voted the best self-service application of 2009 by the Board of the European Association for Self-service (EAFS), during Kiosk Europe Expo 2009, held this May in parallel with Digital Signage Expo 2009 in Essen, Germany.
CardioPod will be installed in pharmacies and GP surgeries across England, allowing patients easy access to an NHS Health Check carried out by a trained professional, who will give expert advice on their cardiovascular risk score and what action they can take to reduce the risk of heart disease, stroke, type II diabetes and kidney disease.
The role of magnetic resonance imaging (MRI) to assess the effect of therapy in patients with acute myocardial infarction was demonstrated in a series of papers presented at the 12th Annual Scientific Sessions of the Society for Cardiovascular Magnetic Resonance (SCMR).
In April, the 75th annual congress of the German Cardiac Society (DGK) was considered a great success, drawing in some 7,900 specialists.
'There is no proof that some new procedures are better than the conventional ones or than clinical examination'
The role of magnetic resonance imaging (MRI) to assess the effect of therapy in patients with acute myocardial infarction was demonstrated in a series of papers during the 12th Annual Scientific Sessions of the Society for Cardiovascular Magnetic Resonance (SCMR), held in Orlando, Fla. USA (29 Jan - 1 Feb).
Less acute heart attacks in Italy five months after the introduction of a smoking ban in indoor public places.
The obesity epidemic is increasingly affecting young teens worldwide. In the USA the epidemic is well-established: more than 17% of children are obese and about a third of those have high blood pressure, which places them at risk for premature heart disease.
Maquet has launched Cardiohelp, the world's smallest, lightest heart-lung machine, that can not only provide a total therapy solution for heart surgery, cardiology, intensive and emergency care, but also, due to its suitcase size and 10 kg weigh, the device can be carried by just one person onto a helicopter or ambulance for mobile use.
Maquet has launched Cardiohelp, the world's smallest, lightest heart-lung machine, that can not only provide a total therapy solution for heart surgery, cardiology, intensive and emergency care, but also, due to its suitcase size and 10 kg weigh, the device can be carried by just one person onto a helicopter or ambulance for mo-bile use.
The common parlance knew it long before experts paid attention to it: a persons mood can be associated to its heart. But indeed in recent years much attention has been spend to depression following heart attack and its effects on prognosis. On the Congress of the European Society of Cardiology (ESC) two Dutch studies have been introduced indicating that especially somatic and incident depression…
Between June 2004 and April 2008 the Dutch DECREASE III Study observed patients treated with Fluvastatin. The results show that Fluvastatin XL therapy can be associated with improved postoperative cardiac outcome in high-risk patients undergoing elective vascular surgery.
Professor C Mueller adressed the issue of new biomarkers in acute cardiac care on the ESC on Monday, 1st September. Read his comment in the following.
Countries vary widely in their capacity to manage hypertension, but globally the majority of diagnosed hypertensives is inadequately controlled. Not treated it can cause cardiovascular disease (CVD), myocardial infarction and stroke. According to the WHO, hypertension is estimated to cause 4.5% of the current global disease burden and is as prevalent in many developing countries as in the…
The diagnostic work-up of syncope patients often raises the question of how much diagnosis is necessary and what examination methods are really needed. To save time, specialists recommend focusing on determining whether the syncope may be caused by a cardiac problem - a question answered quite easily in many cases. Karl Eberius MD, European Hospital's new correspondent, discussed advice for…
Royal Philips Electronics is to lead `euHeart´, the new European Union (EU) funded research project that aims to improve CVD diagnosis, therapy planning and treatment.
Pegasus/Heartview LLC has announced that clinical studies of its HeartVue 6S Heart Screening System - which obtained CE Mark Approval in Europe almost two years ago - have been completed according to FDA guidelines, as a pre-marketing condition for release in the USA.
Among the many aims of the Heart Failure Association of the ESC is the establishment of networks for the HF management, education and research.
The ageing population and growing risk factors have made a significant impact on driving up the number of registered heart failure (HF) cases. Existing pharmacological strategies are improving the survival rates of acute and early-stage HF patients, ironically providing a growing body of patients with progression of the disease to HF.